Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women

BACKGROUND: Following the release of the 2002 report of the Women’s Health Initiative (WHI) trial of estrogen plus progestin, the use of menopausal hormone therapy in the United States decreased substantially. Subsequently, the incidence of breast cancer also dropped, suggesting a cause-and-effect r...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Chlebowski, Rowan T., Kuller, Lewis H., Prentice, Ross L., Stefanick, Marcia L., Manson, JoAnn E., Gass, Margery, Aragaki, Aaron K., Ockene, Judith K., Lane, Dorothy S., Sarto, Gloria E., Rajkovic, Aleksandar, Schenken, Robert, Hendrix, Susan L., Ravdin, Peter M., Rohan, Thomas E., Yasmeen, Shagufta, Anderson, Garnet
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2009
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3963492/
https://ncbi.nlm.nih.gov/pubmed/19196674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0807684
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk